TwinTree Insert


Capitulo veintiuno
Datos y cifras

21-01 Distribución orgánica de los estudios de IRM

he spectrum of clinical MR examinations has hardly changed during the last decade. Brain and spine studies make up more than 50% of all stu­dies, breast, heart and interventional studies less than 5%. fMRI (func­tio­nal brain MRI) and other sophisticated examinations add up to less than 1% of all clinical MR stu­dies (Figure 21-01). Of course, the local distribution differs according to the spe­cia­li­za­tion of the MRI institute.

Figura 21-01:
Overall MR examinations in percent:
Spine 26%; brain 25%; head and neck 6%; upper extremities 11%; lower extremities 9%; abdomen and pelvis 8%; chest 2%; breast (MRM) 2%; cardiac 1%; an­gio­gra­phy (MRA) 9%; other ≤ 1%.
Source: TRTF/EMRF estimates 2023.

• Relative distribution of MR examinations by organ or applications given in Figure 21-01: The per­cen­tage will only slightly change in the future. However, the absolute number of examinations will dras­ti­cal­ly increase — not necessarily for medical reasons, though. There is, for instance, no evidence to justify whole-body screening for people without clinical symptoms or known or imagined risk factors.
• For the "Facts and Figures" section we try to collect data through our own channels. The num­bers pub­li­shed by OECD (Or­ga­ni­za­tion of Economic Cooperation and Development) and WHO (World Health Or­ga­ni­za­tion) are not absolutely dependable, but the best collected data available from international or­ga­ni­za­tions. In many instances, OECD data do not contain the number of units in freestanding imag­ing facilities nor those of state or military owned facilities. In many coun­tries even the re­spon­sible state ad­mi­ni­stra­tions (ministries of health) cannot provide reliable num­bers, nor can the ma­nu­fact­u­rers of MR equipment and those of accessories. For some countries, the number given here may sub­stan­ti­ally differ from those distributed by OECD and WHO. They were collected from insurance or re­im­burse­ment companies or private sources.

spaceholder red

As for "Facts and Figures"
one should listen to Mark Twain:

inkpot Lies, damned lies, and statistics.

spaceholder red

21-02 ¿Cuántas máquinas de resonancia magnética hay?

In the early 1980s, there were 12 machines, and everybody working with MR imaging knew each other. Today, we can just give an impression of magnitudes, a general trend. World­wide, there are perhaps 50,000 MR machines. At pre­sent, about 5,000 MR imaging units are sold worldwide every year. Usually, after an average of seven years, many machines are being replaced or refitted. Therefore the overall number of ma­chi­nes sold does not represent the number of machines in use.

In general, twelve to fifteen machines per one million inhabitants fully satisfy the medical needs of the population. Figure 21-02 gives an overview of the number of MR units in some exemplary countries worldwide.

Figura 21-02:
Top: Overall number of MR machines in some selected countries. Bottom: Machines per 1 million in­ha­bi­tants (TRTF/EMRF estimates, 2020).

US U.S.A.; JP Japan; CN China; DE Germany; BR Brazil; IT Italy; KR South Korea; IN India; RU Russia; ES Spain; FR France; TR Turkey; CA Canada; AU Australia; CH Switzerland; MX Mexico; PL Poland; GR Greece; AE United Arab Emirates; NL The Netherlands; AT Austria; CL Chile; NO Norway; LB Lebanon; FI Finland; IR Ireland; CZ Czech Republic; UA Ukraine; NZ New Zealand; SK Slovakia; IL Israel; HU Hungary; LV Latvia; SI Slovenia; EE Estonia; AL Albania; RS Serbia; LU Luxembourg; IS Iceland.
OECD data for 2022 can be found [⇒ here].

In countries with (over-) saturated markets, e.g., the U.S.A., Japan, Korea, Swi­tzer­land, and Germany, there is a high risk of overuse of MR imaging. According to the OECD [⇒ OECD], between 1997 and 2006, the number of examinations in the U.S.A. has increased dramatically while the occurance of illnesses re­main­ed constant. Furthermore, where payment incentives allow com­pa­nies and physicians to benefit from referrals, the likelihood of overuse increased.

spaceholder red

One also has to see the change of radiologcial health care:

inkpot From individual to chain-employed radiologists.

spaceholder red

21-03 Intensidad de campo de las máquinas de IRM

The choice of an MR system might be quite agonizing. Field strength is one, but not the only and most important, parameter; higher field strength does not gua­ran­tee a better quality system or better diagnostic outcome for the patient. Most appraisals of the "best" equipment are subjective opinions sold as research backed unshakable con­clu­sions. Since there are very few scientifically reliable outcome studies, any claims about superiority of equipment types or best field strength must be looked at cum grano salis (see also Diagnostic accuracy).

Needs must be carefully assessed in the choice of an MR imager. The quality of the component parts, both in terms of hardware and software, makes a con­si­der­able impact. Service, maintenance, and knowledge of how to run the system are of pi­vo­tal im­por­tance for image quality and assessment.

There is no optimum field strength for MR imaging (see Table 03-03 for a com­pari­son between 1.5 T and 3.0 T). Certain MR-based techniques such as func­tio­nal imaging need high fields, clinical MR imaging doesn't. The diverse nature of ap­pli­ca­tions requires different systems operating at an appropriate field; there is no single perfect or ideal field strength for all clinical indications and/or research quest­ions. Image contrast does not necessarily increase with field strength (see Figure 10-16).

Figura 21-03:
Definition of field strength (EMRF 1989). Definitions in publications on MR topics and in sales bro­chu­res change ac­cord­ing to com­mer­cial and scien­ti­fic mar­ket­ing schemes and pre­vail­ing sci­en­ti­fic dogma.

Ultralow equipment (≤ 0.1 T) is hardly used any more, most clinical machines operate at medium and high fields. At present, there is a trend towards ultrahigh research machines, operating between 3 T and 11 T (Figure 21-03) aimed at re­search and commercially competitive sites. At present, there is no proof that such units are of better clinical value than medium or high field ma­chi­nes al­though there are numerous claims of better "patient outcome". Ma­nu­fac­tu­rers try to push them into the clinical market, although it is unlikely that they will be used in clinical set­tings because of their side effects and enormous prices.

MR systems are available in the well-known tunnel shape or as open systems. The latter reduce patient claustrophobia and are better suited for interventional pur­po­ses because there is access to the patient from all sides. Open systems are avail­able between 0.3 T with permanent magnets to 1.5 T with superconducting magnets.

spaceholder red

Some thoughts written about buying an MR eqipment
in the early times of MR imaging …

inkpot … in ten easy lessons

spaceholder red